Related Experiment Video
Updated: Apr 29, 2026

11:14
Acute Brain Trauma in Mice Followed By Longitudinal Two-photon Imaging
Published on: April 6, 2014
13.0K
Multifunctional Nanoparticles in Traumatic Brain Injury: From Targeted Imaging and Diagnosis to Innovative
Nouran Alwisi1, Sarah Aqel2, Janatul Naeim1
1College of Medicine, QU Health, Qatar University, Doha, Qatar.
International Journal of Nanomedicine
|March 27, 2026
Summary
Nanoparticles offer promising solutions for traumatic brain injury (TBI) diagnosis and therapy by overcoming blood-brain barrier challenges. Optimizing nanoparticle design is crucial for effective TBI treatment and minimizing side effects.
Area of Science:
- Neuroscience
- Biomaterials Science
- Nanotechnology
Background:
- Traumatic brain injury (TBI) is a major global health concern with limited treatment options due to the blood-brain barrier (BBB) and complex neurodegeneration.
- Nanoparticle platforms show potential for TBI diagnosis and therapy due to their adaptable properties and multifunctionality.
Purpose of the Study:
- To review nanoparticle applications in TBI diagnosis, neuroimaging, and therapy.
- To discuss design principles for enhancing BBB penetration, targeting specificity, and biodistribution.
- To assess strategies for site-specific delivery and mitigating secondary brain injury.
Main Methods:
- Review of major nanoparticle classes (organic, inorganic, carbon-based, biologically derived).
- Analysis of physicochemical properties influencing CNS interactions.
- Evaluation of design principles for BBB penetration, targeting, biodistribution, and clearance.
Main Results:
- Nanoparticles demonstrate potential for improved imaging contrast, biosensing, and targeted diagnostics.
- Therapeutic applications show promise for concentrating agents at injury sites, but precise delivery remains a challenge.
- Off-target accumulation, incomplete BBB penetration, and heterogeneous distribution are key limitations.
Conclusions:
- Optimizing particle size, charge, ligand conjugation, and degradability is essential for effective TBI nanotherapies.
- Biodegradable, biomimetic, and sustainable nanoparticle synthesis is critical for clinical translation.
- Further research is needed to overcome translational challenges and integrate nanomedicine into TBI clinical management.

